News
Reflections from the International Pandemic Sciences Conference 2024
The historic city of Oxford recently played host to the International Pandemic Sciences Conference 2024, an event that drew over 450 delegates from around the world. Held at the prestigious University of Oxford, the conference…
GADx Contributes to TB Diagnostic Advancements
GADx is pleased to announce its significant contribution to a groundbreaking study published in PLoS One. The research, titled “Performance of Novel Antibodies for Lipoarabinomannan to Develop Diagnostic Tests for Mycobacterium tuberculosis,” showcases the collaborative…
Global Access Diagnostics (GADx) selected as member of ARPA-H Investor Catalyst Hub spoke network
Global Access Diagnostics (GADx) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H). …
Botswana, a major animal health player on the African Continent
In 2023, Botswana hosted the 25th World Organization for Animal Health (WOAH) Regional Commission for Africa conference in Gaborone. At the opening of the event, the Botswana Institute for Technology Research and Innovation (BITRI) presented…
GHLabs x GADx: PoC innovation in molecular diagnostics
The sensitivity of molecular testing is now being revolutionised for point-of-care (PoC) usage. PCR, known for its high sensitivity and specificity, is the gold standard in diagnosing many infectious diseases. However, its availability has been…
Botrytis: How on-site diagnostics can support the wine industry
Botrytis bunch rot is a disease that still afflicts the wine industry. An estimated 25% of the globe’s $66 billion worth of wine grapes produced annually lost due to this disease! This article provides an in-depth look…
Liver fluke test: Developing a rapid test to support farmers in response to antihelminthic resistance
“We are delighted that what started as a research tool is now being developed as a practical diagnostic test for farmers and vets, to support strategic control for this common, devastating disease.” Dr Tessa Walsh,…
New CEO at GADx, Dr Mark Street-Docherty
It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty. Mark brings with him enormous experience of leading…
How in-field diagnostics can reduce waste on farms and promote sustainable agriculture
Did you know that on a global scale up to 40% of crops are lost to pests and diseases? This article provides an overview on the waste associated with farming, contributing to global food insecurity,…
GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…